|
Recent Newsletters
Beta-blockers among people with HIV | Practice sues health system for $50M | Apple hiring a cardiologist |
Excess deaths in the US up 23% | New study highlights the importance of TAVR | A new FDA approval for alirocumab |
Week in Review: Beta-blockers inferior to other therapies | Processed meat & CVD risk | FDA approves Harmony TPV |
Processed meat & CVD risk | ACC's new president | Dapagliflozin benefits both male & female HF patients |
March in Review: Eating meat raises heart disease risk | Vaccine updates | 2-year TAVR data | $506M in lost revenue |
Beta-blockers inferior to other hypertension treatments | GE Healthcare's new AI offering | AFib ablation protocols |
Imaging & Physiology: Low utilization rates for CT perfusion | AI predicts CVD death | CTA for NSTE-ACS |